Metabolomic profiling and prognostication in COVID-19 acute respiratory distress syndrome

• David Furfaro,
• Xiaoyu Che,
• Wenhao Gou,
• Matthew J. Cummings,
• Nischay Mishra,
• Daniel Brodie,
• Thomas Briese,
• Oliver Fiehn,
• W. Ian Lipkin,
• Max R. O'Donnell

Affiliations

David Furfaro

Division of Pulmonary, Critical Care, and Sleep Medicine at Beth Israel Deaconess Medical Center, MA, USA; Corresponding author: David Furfaro, Division of Pulmonary, Critical Care, and Sleep Medicine at Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA 02215, USA.

Xiaoyu Che

Center for Infection and Immunity, Columbia University Irving Medical Center and the Mailman School of Public Health, NY, USA

Wenhao Gou

Center for Infection and Immunity, Columbia University Irving Medical Center and the Mailman School of Public Health, NY, USA

Matthew J. Cummings

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, NY, USA

Nischay Mishra

Center for Infection and Immunity, Columbia University Irving Medical Center and the Mailman School of Public Health, NY, USA

Daniel Brodie

Division of Pulmonary and Critical Care Medicine, The Johns Hopkins University School of Medicine, MD, USA

Thomas Briese

Center for Infection and Immunity, Columbia University Irving Medical Center and the Mailman School of Public Health, NY, USA

Oliver Fiehn

West Coast Metabolomics Center, University of California Davis, CA, USA

W. Ian Lipkin

Center for Infection and Immunity, Columbia University Irving Medical Center and the Mailman School of Public Health, NY, USA

Max R. O'Donnell

Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University Irving Medical Center, NY, USA